Objectives To investigate (1) what Finnish pharmacy customers have learned about the implemented electronic prescriptions (e-prescriptions), (2) from whom or where have they learned about them, (3) whether they are satisfied with the information received and if not, (4) what more information they would like. Methods We surveyed 1288 (44%) pharmacy customers aged ≥18 years collecting medicines for themselves with e-prescriptions in 18 pharmacies across Finland in 2015. Descriptive analysis, chi-square and Fisher's exact tests were used in the analysis. Key findings Nearly all respondents had received information about e-prescriptions (97%). A physician (67%) and a pharmacy (53%) were the most common information sources. The vast majority of the respondents had learned about how to purchase medicines with an e-prescription (86%). Most of them had also received information about the benefits of e-prescriptions (59%) and how they can view their e-prescriptions on a computer (58%). The majority of pharmacy customers felt they had received sufficient information on e-prescriptions (83%). Those dissatisfied with the information received asked for more information about how e-prescriptions are protected against misuse (47%) and who can view their e-prescriptions (44%). Conclusions Most Finnish pharmacy customers have learned how to use e-prescriptions, what their benefits are and how to view e-prescriptions on a computer. The information is generally obtained from physicians and pharmacies. Information needs concern data protection and data security. Customers are mainly satisfied with the information received. However, their knowledge only partly meets the national requirements on the information they should be provided with.
Introduction
Advances in electronic health (e-health) have changed healthcare service procedures during the past decade. New technologies aim to improve patient and medication safety by streamlining healthcare processes and enabling shared access to patients' data. Access has also been offered to patients themselves in order to enable them to participate in their treatment. [1] To adopt their new role, patients need adequate information on the new services and their use.
From patients' perspective, electronic prescriptions (e-prescriptions) are one of the most common and the most significant e-health advances to be introduced. In countries with the most advanced e-prescription systems, prescriptions are issued, stored, transferred and dispensed electronically, with two-way transmission between healthcare provider and pharmacy. [2, 3] The implementation of e-prescriptions has been widely studied from the perspectives of healthcare professionals, [4] [5] [6] [7] but less from the other main user group, patients. [4] Studies surveying patients' experiences have focused on their perceptions of e-prescriptions, [8] [9] [10] experiences with visiting the pharmacy, [11] experiences with using an online service for viewing e-prescriptions [12] and satisfaction with the system. [8, 11, 13] Patients' experiences with e-prescriptions have been very positive [8, 11, 13, 14] and they rarely encounter any problems with them. [11] Despite this, however, a Swedish survey found that medicine users had only limited knowledge of the nationwide e-prescription services. [8] A significant number of the respondents answered 'I do not know' to questions evaluating their attitudes and experiences with the services. This lack of awareness was thought to result from insufficient information and education. Furthermore, respondents' most common suggestion for improving the services was to extend the information provided. In Finland, the national e-prescription pilot project concluded that patients would have liked to receive more information than they were provided with. [15] To the authors' knowledge, no studies have explored medicine users' information sources or information needs during the process of implementing e-prescriptions.
This study aims to investigate the information pharmacy customers have received about the recently introduced eprescription system in Finland. Further objectives were to explore (1) from whom or where customers have learned about e-prescriptions, (2) what have they learned about, (3) have they received sufficient information and (4) what more information they would need.
E-prescriptions and the information obligation in Finland
Finland has phased in e-prescriptions nationwide by law. [16] The Act on Electronic Prescriptions 61/2007 aimed to facilitate prescribing and dispensing as well as improve patient and medication safety. The act outlined how the e-prescribing system operates and what are the policies, obligations and rights of the each party involved. It also provided that the introduction of e-prescriptions was mandatory for all pharmacies and healthcare providers on the given timetable. Pharmacies started to dispense e-prescriptions in 2012 and public health care was mandated to e-prescribing in the following year. Private sector introduced e-prescribing at the beginning of 2015 and that year the proportion of e-prescriptions rose to over 90% of all dispensed prescriptions. [17, 18] Since 2017, all prescriptions should have been electronic.
An e-prescription is issued and signed electronically by a physician. [19] It is stored in the national database (Prescription Centre), from where it can be retrieved and dispensed in any Finnish pharmacy. Patients get their medicines dispensed by showing a social insurance card, other valid ID, or a patient instruction sheet, which contains details of the e-prescription and a bar code readable by the pharmacy's software. If someone else is purchasing medicines on behalf of a patient, one of these documents or other reliable proof is required. Signed consent is needed when a patient authorizes another person to ask for a renewal or a cancellation of an e-prescription or to request a printed summary of his e-prescriptions.
Patients can get up-to-date information on their e-prescriptions by asking at a pharmacy or by logging into the web service called My Kanta pages. [20] Electronic identification such as an online bank ID is required for logging into the service. In addition to electronic storing and ease of purchasing prescription medicines, one of the main advantages to patients is that their overall medication can be viewed by every healthcare professional participating in the treatment. However, patients can deny access to their e-prescriptions via the healthcare services or via My Kanta.
According to the Finnish Act on e-prescriptions, patients must be provided with information on several issues before receiving an e-prescription for the first time (Table 1) . [16] Patients must be told what the e-prescription is and what their rights are. For example, patients have the right to obtain information on where their personal records have been accessed. Patients are also entitled to receive information about the authorities concerned, data security and data protection. The healthcare unit issuing the first e-prescription is required to give the information in written form, verbally or via a secure internet connection. Depending on the procedure of the healthcare unit, information may be given by a receptionist, a nurse or a physician.
In Finland, permanent residents are entitled to use public healthcare services organized by municipalities. [21] Private healthcare sector complements these services. Medicines, except for nicotine replacement therapy, are sold to the public only from community pharmacies. There is at least one pharmacy located nearly every municipality. The privately owned pharmacy system is regulated by Finnish Medicines Agency and consists of nearly 600 pharmacies and 200 subsidiary pharmacies. [22] Furthermore, there are two university-owned community pharmacies: the University Pharmacy of Helsinki with 17 branches across the country and the University Pharmacy of Eastern Finland in Kuopio. University Pharmacies operate in the same way as privately owned community pharmacies.
Methods
The survey A questionnaire survey among pharmacy customers was carried out in autumn 2015. Questionnaires were distributed from 18 different-sized pharmacies across Finland Table 1 Information that a patient is entitled to get from a healthcare unit before receiving an e-prescription for the first time [16] 
Subject
What the e-prescription is Patients' rights related to e-prescriptions Right to check their details stored in the Prescription Centre Right to obtain information on who has viewed and handled their personal information Right to require incorrect information about them is corrected The national e-prescription system and related services and how they operate The authorities arranging e-prescription services On which conditions a patient's e-prescription information can be accessed Patients' right to decide on disclosure of information How a patient's personal information is secured Other essential details related to handling patients' personal data to customers aged ≥18 purchasing medicines for themselves with e-prescriptions. The convenience sample of pharmacies was gathered by recruiting one University Pharmacy branch, one big city pharmacy and one small rural pharmacy from all six regions of the mainland Finland. The number of questionnaires delivered to each pharmacy was adjusted according to the number of prescriptions dispensed daily and varied between 30 and 200. Customers were informed about the study after their medication was dispensed and offered the questionnaire together with an information sheet and a franked envelope for their responses. Pharmacists were not required to keep a list of customers who declined to participate. The questionnaires were handed out as long as there were forms left, but for a maximum of 2 weeks. After the study period, pharmacies reported the number of remaining questionnaires in order to compute the response rate. Altogether, 2915 questionnaires were distributed. Reminders could not be sent as the questionnaire distribution was made randomly by pharmacists.
The questionnaire
The development of the questionnaire (Appendix S1) was based on the objectives set for e-prescriptions by law, [16] the anticipated impacts of e-prescriptions submitted by the government [23] and some previous studies. [8, 15] The fourpage form contained 26 questions regarding the respondent's (1) experiences with purchasing medicines with e-prescriptions, (2) experiences with the My Kanta web service, (3) opinions on the benefits and problems of eprescriptions and (4) information sources and information needs related to e-prescriptions. This article reports data from the last of these. Information sources and things learned were obtained by means of multiple response questions: 'From whom/where have you learned about e-prescriptions?' and 'What did you learn about?' with the opportunity to choose several alternatives (Questions 11 and 12 in the Appendix S1). Options for the latter question (Question 12) were defined in accordance with the information obligation (Table 1) . Furthermore, the respondent's satisfaction with the information given was obtained by asking, 'Do you feel you have received sufficient information about e-prescriptions?' with structured options Yes and No (Question 13 in the Appendix S1). A 'No' was followed by the open-ended question 'What more information would you like?'. Structured questions yielded background information on the respondent's gender, education, area of residence, regularity of prescription medicine use and medicine purchases with e-prescriptions within the previous 6 months (Questions 1, 22 and 24-26 in the Appendix S1). The respondent's year of birth was obtained by means of an open-ended question (Question 23 in the Appendix S1).
The questionnaire was pilot tested in a local pharmacy. The pilot customers were interviewed at the pharmacy after filling in the questionnaires to check that they had understood the questions. Minor modifications were made based on the pilot.
Data analysis
Data were stored and analysed by using the Statistical Package for Social Scientists software (IBM SPSS Statistics for Windows (Version 25.0); IBM Corp., Armonk, NY, USA). In the free-text answers to Question 13, most respondents referred to the previous question, for example 'About all those alternatives I did not circle in Question 12' or 'Alternatives 4 and 6-10 from the previous question'. These answers were categorized deductively into the themes mentioned in Question 12. Answers not referring directly to the previous question were classified into new categories. For example, 'How can I ask for renewal of an e-prescription issued in private healthcare' was categorized as 'Renewal'. However, the categories created other than 'Renewal' were combined as 'Other' since they included only a small number of cases.
A descriptive approach (frequencies, percentages) was used in the analysis. The data were analysed using chisquare or Fisher's exact tests. Statistical significance was determined as P < 0.05. In the analyses, the respondent's age was placed into one of four groups (19-34, 35-59, 60-74 and 75 years or older). In the question 'From whom/ where have you learned about e-prescriptions?' the answer 'a receptionist' was combined with 'a nurse' since nurses can work as health centre receptionists and it may be difficult to say what the education of the person giving information is.
Ethical statement
The study setting and research process complied with both local and national ethical instructions for research. [24] This study required no ethical approval.
Results

Respondents
In total, 1290 pharmacy customers returned the completed questionnaire. Two respondents, however, were excluded since they were younger than 18 years. Consequently, the final study sample was 2913, of whom 1288 (44%) responded.
Background information on the study respondents is presented in Table 2 . The respondents represented all six geographical areas of Finland. The respondents' mean age was 59 (ranging from 19 to 93) and most of them were female. The majority of the respondents had purchased medicines with e-prescriptions several times before the study.
Information sources
Thirty-four respondents (2.7%) reported they had not received information about e-prescriptions from anyone or anywhere. Most of the respondents had learned about e-prescriptions from a physician (n = 854, 66.8%) or from a pharmacy (n = 678, 53.1%) ( Table 3) . A nurse or a receptionist had been the information source in 39.4% of cases (n = 503). About a quarter of the respondents had learned about e-prescriptions from a brochure (n = 346, 27.1%) or from the media, covering TV, radio and newspapers (n = 305, 23.9%).
A physician (P = 0.030) and a nurse or a receptionist (P = 0.005) were information sources for pharmacy customers aged 19-34 years more often than for customers aged 35 or more (Table 3) . Respondents using prescription medicines regularly or both regularly and temporarily had learned about e-prescriptions at a pharmacy more often than those using only temporary medicines (P < 0.001). A brochure was most often read by women, respondents younger than 75 years, those with education higher than basic education (comprehensive school) and those using prescription medicines both regularly and temporarily (P < 0.001, P = 0.008, P = 0.016 and P < 0.001 respectively). Respondents aged 35 or older and those with a vocational qualification or higher education were more likely to have learned about e-prescriptions from the media compared to younger respondents and respondents with only a basic education (P = 0.007 and P = 0.002 respectively). The Internet was less likely to be an information source for the oldest respondents and those with a basic education compared to younger and more educated customers (P < 0.001 for both).
Things learned
The majority of the respondents were told how to purchase medicines with an e-prescription (n = 1000, 85.5%; Table 4 ). Most of them had received information about the benefits of e-prescriptions (n = 691, 58.8%) and how to view their e-prescriptions via the My Kanta web service (n = 680, 57.8%). Approximately a third of the respondents were informed where e-prescriptions are stored (n = 466, 39.6%), how another person can purchase medicines on their behalf with an e-prescription (n = 386, 32.8%) and who can view their e-prescriptions (n = 334, 28.4%). By contrast, respondents had rarely received information about their right to limit access to their e-prescriptions (n = 180, 15.3%), how their personal data is protected against misuse (n = 174, 14.8%) or which authorities arrange the e-prescription services (n = 110, 9.4%).
Respondents aged 75 or older and respondents with only a basic education were unlikely to be told about the My Kanta web service (P < 0.001 for both) and where e-prescriptions are stored (P = 0.013 and P = 0.001 respectively) compared to younger and more educated respondents ( Table 4 ). The oldest respondents were more often informed how someone else can purchase medicines on their behalf (P < 0.001), whereas the youngest were informed how to purchase medicines with e-prescriptions (P = 0.009). The latter information was also more likely to be given to customers with a secondary school education or a university degree (P = 0.001) compared to those with a lower education. Respondents using prescription medicines regularly or both regularly and temporarily had received information on the My Kanta service more often than those using prescription medicines only temporarily (P = 0.003). Customers using both regular and temporary prescribed medicines were also likely to have been informed about where e-prescriptions are stored (P = 0.001) and how someone else can purchase their medicines with e-prescriptions (P < 0.001).
Information needs
The majority of the respondents felt they had received sufficient information on e-prescriptions (n = 1030, 83.3%). Respondents aged 35 or older and respondents with an education lower than a university degree were more likely to be satisfied with the level of information received (P = 0.003 and P = 0.001 respectively) than younger and more educated respondents (Table 5) .
However, 16.7% (n = 207) were dissatisfied with the information they received about e-prescriptions. Approximately half of those who specified what more information they would need (n = 179) wanted to know how e-prescriptions are protected against misuse (n = 84, 46.9%) and who can view their e-prescriptions (n = 79, 44.1%) ( Table 6) . A third of them asked for information on the purposes for which their e-prescription information can be used (n = 66, 36.9%), how they can view their e-prescriptions on a *Some of the respondents did not report their gender, age, education, usage of prescription medicines, area of residence or how many times they had purchased medicines with an e-prescription within the last 6 months. Information received and needed on e-prescriptions Elina Lä msä et al. computer (n = 66, 36.9%), what rights they have to limit access to their e-prescriptions (n = 65, 36.3%) and which authorities arrange services related to e-prescriptions (n = 60, 33.5%).
Discussion
Most Finnish pharmacy customers felt they had received sufficient information on the recently implemented e-prescriptions. The principal information sources were a physician and a pharmacy. In most cases, customers were informed how to use e-prescriptions, what their advantages are and how e-prescriptions can be viewed online. Customers' information needs were mainly related to data protection and data security. As the e-prescription reform aimed to improve the safety and quality of care as well as to ease managing of prescriptions, it is important that patients have adequate knowledge to use the services. The results of this study guide Finnish stakeholders what information should still be provided for different patient groups and give implications for other countries implementing e-prescriptions in their healthcare systems. This study has several strengths. First, the results are based on experiences with a fully operational, nationwide e-prescription system. Second, the number of pharmacy customers involved in the survey was high and covered the whole country. Finally, to the authors' knowledge, this is the first study surveying information sources, things learned and information needs related to e-prescriptions. The study adds valuable information to this little studied field of medicine users' experiences with e-prescriptions.
Nearly all respondents had received information about eprescriptions from at least one source. Physicians and pharmacies were most commonly the providers of the information, corresponding with previous studies exploring Finnish citizens' sources of medicine information. [25] [26] [27] Pharmacies play a significant role in providing e-prescription information without an actual obligation defined by law. Thus, pharmacists have not had consistent instructions how to educate customers. According to the Act on Electronic Prescriptions 61/2007, healthcare providers must inform patients about certain matters either verbally or in written form. [16] Patients are always entitled to get the information in writing so that they can refer to it later. The authorities arranging e-prescription services have published official brochures to be offered as written information. In this study, only one-fourth of the pharmacy customers had used a brochure as an information source. It remains unclear whether other respondents had received the brochure.
Even though most of the pharmacy customers were satisfied with the information received, they lacked information on several matters mandated by law. [16] However, this study was based on customers' experiences, which means recall bias is possible. The vast majority of the respondents had obtained the most essential information, namely how to use e-prescriptions. Furthermore, most of them had been informed about the benefits of e-prescriptions, which may promote their adoption of the service. Customers of different ages and education levels had commonly received information about different matters. The oldest pharmacy customers, those with the lowest education and those using Statistically significant P-values (P < 0.05) are in bold. † For example, how to purchase medicines with e-prescriptions (n = 14), 'everything' (n = 8), travelling abroad (n = 3).
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prescription medicines only temporarily had rarely received information about the My Kanta web service. In our earlier study, the same groups reported being unfamiliar with the service. [12] In addition, the oldest customers were likely never to have used the service. As the paperless e-prescribing process has made it difficult for some medicine users to keep up to date with their prescriptions, [9, 10, 13, [28] [29] [30] providing information on the web service is also essential in terms of medication safety.
A fifth of the study respondents felt they had received insufficient information about e-prescriptions. This is in line with a Swedish population survey, in which one-fifth of the respondents regarded information on e-prescriptions received from a physician or a pharmacy as poor. [8] In our study, most of those asking for more information were interested in data security and data protection of e-prescriptions. The security of electronic storing, transferring and sharing of health information has concerned lay people in earlier studies. [15, [31] [32] [33] [34] [35] [36] [37] Concerns and suspicions have related to the persons viewing and handling health information [31, 37] and how the information is protected from unauthorized access. [15, 32, 33] Respondents have been unwilling to share their personal health information even with dispensing pharmacists [31] or for their anonymized information to be used for research and development purposes. [37] In the United States, physicians perceived patients' distrust as one of the barriers to more extended e-prescribing. [38] Insufficient information on procedures and data protection can partly explain patients' suspicions. Thus, in order to encourage consumers' acceptance, it is important to include these issues in the information provided on e-health services.
From the ten legally required pieces of information, only three had been learned by the majority of the survey respondents. Surprisingly, information about how to purchase medicines and the benefits of e-prescriptions as well as the lack of information about data security and data protection were also reported by test patients of the Finnish e-prescribing pilot project in 2006. [15] The recommendations of the present study correspond with those of the final report of the pilot project: we need to improve the information on how patients can obtain up-to-date information on their eprescriptions, how the e-prescription system is secured and what the privacy policies are.
To understand and learn about a new healthcare reform, lay people evidently need the information repeated several times. Thus, extending the information obligation from healthcare units to pharmacies would better ensure medicine users obtain sufficient information on e-prescriptions. Providing the information stepwise would be sensible as customers gain experience with e-prescriptions and are better prepared to understand more advanced subjects. This study found that young and highly educated pharmacy customers would like to learn more about e-prescriptions and related services. Unlike older and less educated respondents, they may be more aware of modern electronic devices and services and therefore have more questions about them. The information needs of the groups covered in this study should be better considered during future reforms.
Since this study was conducted, Finnish e-prescription services have increasingly appeared in both traditional and social media and now reach people more widely than reported in this article. The system has also been further developed: for example, people can ask for a renewal of their e-prescriptions and view e-prescriptions of their dependents on the My Kanta web service. The findings of this study represent pharmacy customers' knowledge of new e-prescription services during the first few years of their implementation. Future studies should explore people's knowledge of the services and information needs now that the use of the e-prescription system has taken root.
Our method has some limitations. Because the questionnaire was distributed by dispensing pharmacists, we lack background information on the customers to whom the questionnaire was offered and who accepted it. We were therefore unable to send reminders. However, the response rate of 44% corresponds with that of three other surveys among customers purchasing prescription medicines from Finnish pharmacies. [39, 40] The majority of our study respondents were women, but the distribution by gender, age and use of prescription medicines was similar to those of an earlier study conducted using a similar method. [40] Consequently, we assume the study population well represents those customers purchasing their prescription medicines at Finnish pharmacies.
Conclusions
This study was the first to explore medicine users' information sources and information needs during the nationwide implementation of e-prescriptions. Physicians and pharmacies are the most common e-prescription information sources for Finnish pharmacy customers. Most of them have learned how to purchase medicines with e-prescriptions, what their benefits are and how to view e-prescriptions on a computer. Customers asking for more information are interested in data security and data protection. We found that most Finnish pharmacy customers are satisfied with the information they have received on the recently introduced e-prescription system. However, their knowledge only partly meets the requirements of the Act on Electronic Prescriptions.
Based on this study, we can recommend that the dissemination of information to lay people should be planned thoroughly and carried out carefully during the nationwide introduction of e-prescriptions. Information should be provided repeatedly and consistently by all healthcare providers and pharmacies, who should also be well trained to meet their obligations.
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